Modified Duke criteria (definite vs possible IE)
Definite IE:
- 2 major, OR
- 1 major + 3 minor, OR
- 5 minor criteria.
Possible IE:
- 1 major + 1 minor, OR
- 3 minor.
Major criteria
1. Positive blood cultures
- 2 separate BCx with typical organisms: viridans strep, S. aureus, S. bovis (S. gallolyticus), HACEK group, community-acquired enterococci without a primary focus.
- OR persistently positive: BCx > 12 hr apart, or 3 of 3 / majority of ≥ 4 separate BCx (first and last drawn ≥ 1 hr apart).
- OR single positive BCx for Coxiella burnetii, or phase 1 IgG anti-Coxiella titer > 1:800.
2. Evidence of endocardial involvement (echo)
- Oscillating intracardiac mass on valve/supporting structure/path of regurgitant jet/implanted material with no alternative explanation.
- Abscess.
- New partial dehiscence of a prosthetic valve.
- New valvular regurgitation (increase in a prior murmur is not sufficient).
Minor criteria
- Predisposition (heart condition or IV drug use).
- Fever > 38.0 °C (100.4 °F).
- Vascular phenomena - major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, ICH, conjunctival hemorrhages, Janeway lesions.
- Immunologic phenomena - glomerulonephritis, Osler nodes, Roth spots, rheumatoid factor.
- Microbiologic evidence not meeting major criterion.
Detection sensitivity
- Smallest left-sided vegetation detectable: TTE 5 mm, TEE 1 mm.
- TTE sensitivity 62–82 %; specificity 91–100 %.
- TEE sensitivity 87–100 %; specificity 91–100 %.
- With Staph aureus bacteremia and a NEGATIVE TTE without clinical signs, the chance IE is missed if TEE is skipped is ~15 %.
Anatomic tendencies
- Vegetations settle on the upstream (low-pressure) surface of the valve.
- Ventricular surface of AV in AI.
- Atrial surface of MV in MR.
- Downstream-surface masses are more often degenerative (papillary fibroelastoma, chordal masses).
- IE more common on previously abnormal (turbulent) valves.
Mimics of IE
- Papillary fibroelastoma (typically on the aortic side of AV; small, pedunculated).
- Myxomatous mitral valve disease.
- Nonbacterial thrombotic (marantic) endocarditis - malignancy (esp. mucinous adenocarcinoma), SLE (Libman-Sacks).
- Antiphospholipid syndrome - large valvular masses, "kissing" lesions at any location; tissue destruction usually absent (its presence should raise concern for IE).
- Prosthetic valve thrombus.
- Beam-width artifact.
- Normal variants: Lambl's excrescences, Arantius nodules.
Perivalvular complications
Abscess
- Localized abnormal thickening of perivalvular tissue or an echolucent cavity that does NOT communicate with cardiac chambers.
- Most common location: aortic root and aorto-mitral intervalvular fibrosa.
- Best view: PSAX of the aortic valve (TEE mid-esophageal 45–60°).
- Early sign: abnormal thickening (echo-dense) of the aortic root > 10 mm; over time echolucency develops.
- Complications: extrinsic compression of left main coronary artery → high-velocity diastolic LMCA flow; myocardial abscess → AV block (septal abscess); pericardial fistula.
Pseudoaneurysm
- Abscess that has established communication with the aortic lumen - localized bulging (best seen in systole).
Fistula
- Abscess erodes aortic root → communicates with another chamber.
Leaflet perforation
- Origin of regurgitant jet away from the coaptation line → leaflet perforation.
Mitral valve aneurysm (from posteriorly-directed AI jet)
- Localized systolic bulge of AMVL toward LA (expands in systole, collapses in diastole).
- Perforation of aneurysm → MR (color shows systolic flow crossing into LA).
- Repair with pericardial patch preferred over replacement.
Prosthetic valve endocarditis - special considerations
- TEE is essential. Reverberations/shadowing limit TTE.
- Infection often involves the sewing-ring area rather than a discrete valvular vegetation.
- Look for: perivalvular regurg, dehiscence with rocking > 15°, annular bulging.
Indications for early surgery
- Valve dysfunction with heart failure.
- Resistant organism (Staph aureus, fungus).
- Heart block (suggests abscess).
- Perivalvular abscess.
- Large mobile vegetation (> 10 mm) with severe valve disease.
- Persistent bacteremia despite antibiotics.
- Prosthetic valve endocarditis.
- Recurrent embolization.
- Right-sided TV vegetation > 2.5 cm → high embolic risk → replacement.
Antibiotic prophylaxis (2020 AHA/ACC) - highest-risk groups only
- Prosthetic heart valves (including TAVR) or prosthetic material used in valve repair.
- Prior IE.
- Cardiac transplant with valvular dysfunction.
- Congenital heart disease:
- Unrepaired cyanotic CHD (including palliative shunts).
- Repaired CHD with prosthetic material within 6 months.
- Repaired CHD with residual defects at/near prosthetic material.
Not recommended for TEE, upper endoscopy, colonoscopy, cystoscopy without ongoing infection.
Recommended before dental procedures involving gingival/periapical/oral mucosal manipulation.
Post-treatment findings
- Successful ABX: vegetations shrink and become more echodense.
- Persistence alone does NOT predict worse outcome.
- Lack of vegetation regression after 4–6 weeks with progressive valve disruption → higher mortality.
- < 10 % of affected valves regain normal structure after healing.